197 related articles for article (PubMed ID: 31712427)
21. Involvement of Receptor Activity-Modifying Protein 3 (RAMP3) in the Vascular Actions of Adrenomedullin in Rat Mesenteric Artery Smooth Muscle Cells.
Chauhan M; Yallampalli U; Banadakappa M; Yallampalli C
Biol Reprod; 2015 Nov; 93(5):116. PubMed ID: 26423127
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.
Dai K; Tanaka M; Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Kawate H; Cui N; Wei Y; Tanaka M; Kakihara S; Matsui S; Shindo T
Oncogene; 2020 Feb; 39(9):1914-1930. PubMed ID: 31754214
[TBL] [Abstract][Full Text] [Related]
23. Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system.
Yamauchi A; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Igarashi K; Toriyama Y; Tanaka M; Liu T; Xian X; Imai A; Zhai L; Owa S; Arai T; Shindo T
J Mol Cell Cardiol; 2014 Dec; 77():73-85. PubMed ID: 25264174
[TBL] [Abstract][Full Text] [Related]
24. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
[TBL] [Abstract][Full Text] [Related]
25. GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs.
Barbash S; Lorenzen E; Persson T; Huber T; Sakmar TP
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12015-12020. PubMed ID: 29078385
[TBL] [Abstract][Full Text] [Related]
26. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.
Kuwasako K; Hay DL; Nagata S; Murakami M; Kitamura K; Kato J
Curr Protein Pept Sci; 2013 Aug; 14(5):416-28. PubMed ID: 23745705
[TBL] [Abstract][Full Text] [Related]
27. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
[TBL] [Abstract][Full Text] [Related]
28. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of two human receptor activity-modifying protein 3 variants.
Bailey RJ; Bradley JW; Poyner DR; Rathbone DL; Hay DL
Peptides; 2010 Apr; 31(4):579-84. PubMed ID: 20034525
[TBL] [Abstract][Full Text] [Related]
30. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
31. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
[TBL] [Abstract][Full Text] [Related]
32. The role of glutamic acid 73 in adrenomedullin interactions with rodent AM2 receptors.
Halim A; Hay DL
Peptides; 2012 Jul; 36(1):137-41. PubMed ID: 22546239
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
Armour SL; Foord S; Kenakin T; Chen WJ
J Pharmacol Toxicol Methods; 1999 Dec; 42(4):217-24. PubMed ID: 11033437
[TBL] [Abstract][Full Text] [Related]
34. Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on
Kleist AB; Peterson F; Tyler RC; Gustavsson M; Handel TM; Volkman BF
Methods Cell Biol; 2019; 149():259-288. PubMed ID: 30616824
[TBL] [Abstract][Full Text] [Related]
35. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
36. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
[TBL] [Abstract][Full Text] [Related]
37. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
Morfis M; Tilakaratne N; Furness SG; Christopoulos G; Werry TD; Christopoulos A; Sexton PM
Endocrinology; 2008 Nov; 149(11):5423-31. PubMed ID: 18599553
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed analysis of the secretin-like GPCR-RAMP interactome.
Lorenzen E; Dodig-Crnković T; Kotliar IB; Pin E; Ceraudo E; Vaughan RD; Uhlèn M; Huber T; Schwenk JM; Sakmar TP
Sci Adv; 2019 Sep; 5(9):eaaw2778. PubMed ID: 31555726
[TBL] [Abstract][Full Text] [Related]
39. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
40. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
Kamitani S; Sakata T
Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
